Prot# DR-PSE-309: Mltctr, Opn-Lbl Study to Eval. Efficacy & Safety of Extended Cycle, Low Dose, Cmbnt'n Oral Contraceptive Regimen, DP3-Lo 84/10, Which Utilizes Ethinyl Estradiol During 7 Day Interval Bt/wn Each 84-Day Cycle of Cmbnt'n Therapy for Prevent

Project: Research project

Project Details

StatusFinished
Effective start/end date10/6/05 → 12/4/07

Funding

  • Barr Laboratories Inc. (DR-PSE-309 // DR-PSE-309)
  • Duramed Pharmaceuticals, Inc. (DR-PSE-309 // DR-PSE-309)